Source: Annual Congress 2004 - Pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. J. Reesink, R. Lutter, J. J. Kloek, H. M. Jansen, P. Bresser (Amsterdam, The Netherlands). Hemodynamic correlates of endothelin-1 in chronic thromboembolic pulmonary hypertension. Eur Respir J 2004; 24: Suppl. 48, 768

Member's Comments

No comment yet.

Related content which might interest you: Acute hemodynamic effects of riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Vasodilator treatment in chronic thromboembolic pulmonary hypertension Source: Annual Congress 2003 - Update on chronic thromboembolic pulmonary hypertension Year: 2003 Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 53 (6) 1802004; 10.1183/13993003.02004-2018 Year: 2019 Limitations of resting haemodynamics in chronic thromboembolic disease without pulmonary hypertension Source: Eur Respir J, 53 (1) 1801787; 10.1183/13993003.01787-2018 Year: 2019 Peculiarities of chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 236s Year: 2002 Acute haemodynamic effects of adaptive servoventilation therapy in patients with pulmonary arterial hypertension and patients with chronic thromboembolic pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: management Year: 2015 Pulmonary function in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 Surgical and post-operative treatment of chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2009; 19: 64-67 Year: 2010 Predictors of physical activity in pulmonary arterial and chronic thromboembolic pulmonary hypertension Source: International Congress 2019 – Chronic thromboembolic pulmonary hypertension Year: 2019 Chronic thromboembolic pulmonary hypertension Source: International Congress 2017 – Russian Programme 2017 Year: 2017 Chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 53 (1) 1801915; 10.1183/13993003.01915-2018 Year: 2019 Chronic thromboembolic pulmonary hypertension Source: International Congress 2015 – ME5 Chronic thromboembolic pulmonary hypertension Year: 2015 Chronic thromboembolic pulmonary hypertension Source: International Congress 2018 – State of the art session: Pulmonary vascular diseases Year: 2018 Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology Source: Eur Respir Rev 2009; 19: 59-63 Year: 2010 Evaluation of serum cytokines in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension with hypercholesterolemia Source: International Congress 2017 – PAH and CTEPH Year: 2017 Chronic thromboembolic pulmonary hypertension Source: Annual Congress 2007 - Update on venous thromboembolism Year: 2007 Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2004; 23: 595-600 Year: 2004 Hemodynamic testing of acute vasoreagibility to sildenafil in patients with severe pulmonary hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 705s Year: 2004 Plasma big-endothelin and hemodynamics in patients with pulmonary arterial hypertension compared to patients with chronic left heart failure with and without pulmonary venous hypertension Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Comparison of clinical characteristics in patients with pulmonary arterial hypertension and inoperable chronic thromboembolic pulmonary hypertension Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008